CAHILL BRIAN JOSEPH (Chief Financial Officer) reported 1 transaction at EAGLE PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/6/2024ACC: 0001415889-24-002831
Officer· Chief Financial Officer
Since Oct 2020
-934.00
Net shares
Net seller
$5.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
934.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−934.00
Price / share
$5.85
Trade value
$5.46K
% of position
2.0%
2/2/2024
46.68K→45.75K
Total
Net shares
−934.00
Net value
-$5.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2024 | F · Tax Withholding | −934.00 | $5.85 | $5.46K | 2.0% | 46.68K | 45.75K |
| Total | −934.00 | -$5.46K | ||||||
Derivative Transactions0
No derivative transactions reported